Organon & Co | OGN - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Bristol-Myers Squibb 10.44 5.7 2026-09
Celltrion 41.5 17.47 2026-06
Cspc Pharmaceutical 23.62 0.78 2026-03
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 84.22 25.87 2026-09
Gilead Sciences 17.68 4.18 2026-09
Glaxosmithkline 15.17 0.08 2026-09
Kangmei Pharma 1.11K 0 2026-06
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Malin Corporation 11.81 0.72 2023-06
Merck 34.36 2.11 2026-09
Neuren Pharmaceuticals 72.14 59.86 2025-12
Novartis 21.54 0.18 2026-09
Organigram Holdings 15.55 3.54 2026-06
Organon & Co 17.56 3 2026-09
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 24.29 7.94 2026-09
Qiagen NV 23.09 6.37 2026-09
Sartorius 47.29 5.7 2026-09
Sino Biopharmaceutical 17.03 0.89 2025-06
Tilray 11.56 80.19 2025-09
Zealand Pharma A/S 3.27 1.86 2026-03